Zobrazeno 1 - 10
of 2 275
pro vyhledávání: '"newly diagnosed glioblastoma"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yun Guan, Mingyuan Pan, Jun Yang, Qiuxia Lu, Liangfu Han, Ying Liu, Jing Li, Huaguang Zhu, Xiu Gong, Guanghai Mei, Xiaoxia Liu, Li Pan, Jiazhong Dai, Yang Wang, Enmin Wang, Xin Wang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background The most frequently diagnosed primary brain tumor is glioblastoma (GBM). Nearly all patients experience tumor recurrence and up to 90% of which is local recurrence. Thus, increasing the therapeutic ratio of radiotherapy using hypo
Externí odkaz:
https://doaj.org/article/8a77e026d98443e1ada513bba5e8c2e2
Publikováno v:
Frontiers in Neurology, Vol 13 (2023)
ObjectiveTumor-treating fields (TTFields) are a new therapeutic modality for patients with glioblastoma (GBM). However, studies on survival outcomes of TTFields are rarely reported in China. This study aimed to examine the clinical efficacy and safet
Externí odkaz:
https://doaj.org/article/23a7bcd5a28b46eaaecc57f0750f1549
Autor:
Frontiers Production Office
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/03ad016ec5e34cb295f5b972d855247e
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/3766c41d65664676962c68b54b95f75b
Autor:
Dorte S. Nørøxe, Christina W. Yde, Olga Østrup, Signe R. Michaelsen, Ane Y. Schmidt, Savvas Kinalis, Mathias H. Torp, Jane Skjøth‐Rasmussen, Jannick Brennum, Petra Hamerlik, Hans S. Poulsen, Finn C. Nielsen, Ulrik Lassen
Publikováno v:
Molecular Oncology, Vol 14, Iss 11, Pp 2727-2743 (2020)
Glioblastoma (GBM) is an incurable brain tumor for which new treatment strategies are urgently needed. Next‐generation sequencing of GBM has most often been performed retrospectively and on archival tissue from both diagnostic and relapse surgeries
Externí odkaz:
https://doaj.org/article/d0baf8c1908b4eccb7b839bb49a9e326
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundUnderstudied elderly patients comprise a large segment of high-risk patients with glioblastoma (GBM) that are challenging to treat. Tumor Treating Fields (TTFields) is a locoregional, noninvasive, antimitotic therapy delivering low-intensit
Externí odkaz:
https://doaj.org/article/e7c53c81dcf5413ca0b0ff9060ee0364
Autor:
Montserrat Lara-Velazquez, Jack M. Shireman, Eric J. Lehrer, Kelsey M. Bowman, Henry Ruiz-Garcia, Mitchell J. Paukner, Richard J. Chappell, Mahua Dey
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmunotherapy for GBM is an emerging field which is increasingly being investigated in combination with standard of care treatment options with variable reported success rates.ObjectiveTo perform a systematic review of the available data to
Externí odkaz:
https://doaj.org/article/11e2725c11c44074807e6235d50338bd
Autor:
Antonio Omuro, Alba A Brandes, Antoine F Carpentier, Ahmed Idbaih, David A Reardon, Timothy Cloughesy, Ashley Sumrall, Joachim Baehring, Martin van den Bent, Oliver Bähr, Giuseppe Lombardi, Paul Mulholland, Ghazaleh Tabatabai, Ulrik Lassen, Juan Manuel Sepulveda, Mustafa Khasraw, Elodie Vauleon, Yoshihiro Muragaki, Anna Maria Di Giacomo, Nicholas Butowski, Patrick Roth, Xiaozhong Qian, Alex Z Fu, Yanfang Liu, Von Potter, Alexandros-Georgios Chalamandaris, Kay Tatsuoka, Michael Lim, Michael Weller
Publikováno v:
Neuro-Oncology, 25(1), 123-134. Oxford University Press
Background Addition of temozolomide (TMZ) to radiotherapy (RT) improves overall survival (OS) in patients with glioblastoma (GBM), but previous studies suggest that patients with tumors harboring an unmethylated MGMT promoter derive minimal benefit.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b68a372718b84388b72b49366cf2a9da
https://doi.org/10.1093/neuonc/noac099
https://doi.org/10.1093/neuonc/noac099
Autor:
Zhe Zhang, Zeping Jin, Dayuan Liu, Yang Zhang, Chunzhao Li, Yazhou Miao, Xiaohan Chi, Jie Feng, Yaming Wang, Shuyu Hao, Nan Ji
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundThe extent of resection of non-contrast enhancing tumors (EOR-NCEs) has been shown to be associated with prognosis in patients with newly diagnosed glioblastoma (nGBM). This study aimed to develop and independently validate a nomogram integ
Externí odkaz:
https://doaj.org/article/a0a95dd618144c8c9918f5e92c5cab68